CD163 and cancer: ,70 In agreement with these findings, the TAM component in SIA, the CD68+CD163+ cells in our study were characterised primarily by the expression of M2 markers but also expressed some M1 markers, illustrating the shortcomings of the M1/M2 classification in the cancer context.